文献速递真实世界研究与卫生经济流行病学与生物统计

居家红外测温降低糖尿病足溃疡复发:DIATEMP随机对照试验方案

The cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes (DIATEMP): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-09-24

DIATEMP是一项多中心、结局评估者盲法的随机对照试验,计划纳入304例伴周围神经病变及足溃疡史或Charcot神经骨关节病的糖尿病患者,比较常规护理联合居家每日足部红外测温(增强治疗)与常规护理。主要结局为每例无足溃疡患者的成本(成本-效果)和每获得一个质量调整生命年的成本(成本-效用),临床主要结局为18个月随访期间足底等部位溃疡复发比例。

要点

  • 高危糖尿病患者居家每日足部红外测温是早期识别溃疡前兆的可行方法。
  • 足部对侧温差>2.2°C持续两天时,患者应联系足病医生并将步行活动减少50%。
  • 该试验将评估居家测温预防溃疡复发的成本-效果与成本-效用。

核心结论

  • 居家足部温度监测在溃疡预防中的效力若被证实,结合其可用性、成本-效果和成本-效用评估,可能推动其在荷兰及全球医疗中应用。

研究设计与样本

  • 多中心、结局评估者盲法、随机对照试验,计划纳入304例I型或II型糖尿病患者。
  • 纳入标准为基于周围神经病变的保护性感觉丧失,且过去4年内有足溃疡史或诊断为Charcot神经骨关节病。
  • 增强治疗组在常规护理基础上,居家每日测量足部6至8个预定义位置的温度。
  • 对照组接受常规护理。

主要发现

  • 主要结局为每例无足溃疡患者的成本(成本-效果)和每获得一个质量调整生命年的成本(成本-效用)。
  • 临床主要结局为18个月随访期间足底、足趾顶端面、趾间或前足内侧和外侧面的足溃疡复发患者比例。

关键数值与推荐

  • 若连续两天发现对侧足温差>2.2°C,参与者应联系足病医生进行进一步足部诊断或治疗,并将步行活动减少50%直至温度恢复正常。

临床怎么用

  • 高危糖尿病患者可每日居家测量足部预定义位置温度,发现对侧温差>2.2°C持续两天时联系足病医生并减少步行活动50%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Home monitoring of foot temperatures in high-risk diabetes patients proves to be a promising approach for early recognition and treatment of pre-signs of ulceration, and thereby ulcer prevention. Despite previous studies demonstrating its efficacy, it is currently not widely applied in (Dutch) health care. METHODS: In a multicenter, outcome-assessor-blinded, randomized controlled trial, 304 patients with diabetes mellitus types I or II, loss of protective sensation based on peripheral neuropathy, and a history of foot ulceration in the preceding 4 years or a diagnosis of Charcot neuro-osteoarthropathy will be included. Enhanced therapy will consist of usual care and additional at-home daily measurement of foot temperatures at six to eight predefined locations on the foot. If a contralateral foot temperature difference of > 2.2 °C is found on two consecutive days, the participant is instructed to contact their podiatrist for further foot diagnosis or treatment, and to reduce ambulatory activity by 50% until temperatures are normalized. Enhanced therapy will be compared to usual care. The primary outcomes are the cost (savings) per patient without a foot ulcer (i.e., cost-effectiveness) and per quality-adjusted life year gained (i.e., cost-utility). The primary clinical outcome in the study is the proportion of patients with foot ulcer recurrence on the plantar foot, apical surfaces of the toes, the interdigital spaces or medial and lateral forefoot surfaces during 18-month follow-up. DISCUSSION: Confirmation of the efficacy of at-home foot temperature monitoring in ulcer prevention, together with assessing its usability, cost-effectiveness and cost-utility, could lead to implementation in Dutch health care, and in many settings across the world. TRIAL REGISTRATION: Netherlands Trial Registration: NTR5403 . Registered on 8 September 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Aan de Stegge WB, Mejaiti N, van Netten JJ, et al. The cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes (DIATEMP): study protocol for a randomized controlled trial. Trials. 2018. PMID: 30249296. doi:10.1186/s13063-018-2890-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。